Biogen Idec, Inc. (BIIB) Reports Solid Q2 Results
Tweet Send to a FriendGet Alerts BIIB Hot Sheet
Price: $232.64 +0.57%
Revenue Growth %: +8.5%
Financial Fact:
Basic earnings per share attributable to Biogen Idec Inc.: 1.24
Today's EPS Names:
DSX, REDF, REX, More
Revenue Growth %: +8.5%
Financial Fact:
Basic earnings per share attributable to Biogen Idec Inc.: 1.24
Today's EPS Names:
DSX, REDF, REX, More
Trade BIIB Now!
Biogen Idec, Inc. (NASDAQ: BIIB) reported Q2 EPS of $1.82, $0.26 better than the analyst estimate of $1.56. Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.33 billion.
For earnings history and earnings-related data on Biogen Idec, Inc. (BIIB) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Biogen Idec, Inc. (BIIB) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- NetApp (NTAP) Tops Q4 EPS by 1c; Boosts Buyback, Plans Job Cuts, Initiates Dividend
- UPDATE: Intuit, Inc. (INTU) Tops Q3 EPS by 4c, Offers Guidance
- Lowes Cos. (LOW) Misses Q1 EPS by 2c; Reaffirms FY13 Outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
